Testing if healthy gut bacteria can boost immunotherapy for advanced bowel cancer
Part of Cancer, Digestive system, Immune system & allergy clinical trials.
This trial tests whether transferring healthy gut bacteria can help make immunotherapy more effective for people with advanced bowel cancer that didn't respond to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have metastatic colorectal cancer that is MSS type (a certain genetic profile).
- Your cancer has gotten worse after first chemotherapy and targeted therapy.
- You are well enough to be up and about at least half the day (ECOG 0-1).
- You have not had a fecal microbiota transplant before.
- Your heart, lungs, liver, and kidneys are functioning well.
- You do not have another cancer, a major mental health condition, or are pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This trial tests whether a treatment called fecal microbiota transplant (FMT) — transferring healthy gut bacteria — can help relieve diarrhea and colitis caused by immunotherapy drugs. If you have melanoma or kidney cancer and are experiencing diarrhea after immunotherapy, this study may offer a new option.
This trial tests whether adding a fecal microbiota transplant (FMT) to standard first-line chemotherapy can help shrink or control advanced colorectal cancer that cannot be surgically removed. FMT is a procedure that introduces healthy donor bacteria into your gut to possibly boost your body's response to treatment.
This trial studies whether changes in gut bacteria can help predict how well immunotherapy works for solid cancers. It also tests whether stool (fecal microbiota) from certain immunotherapy-responding people can improve outcomes for others who are not responding well.
This trial tests a treatment called “washed microbiota transplant,” which transfers healthy gut bacteria to help relieve intestinal problems that started after cancer therapy. You might benefit if you’re an adult with certain ongoing stomach or bowel symptoms after standard cancer treatment, and your body is stable enough for the procedure.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
Hear when a new Fecal Microbiota Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.